Acquired mutations in PIGA gene gives rise to:
First, I need to recall what the PIGA gene does. PIGA stands for Phosphatidylinositol Glycan Anchor. It's involved in the synthesis of glycosylphosphatidylinositol (GPI) anchors. GPI anchors are crucial for attaching certain proteins to the cell membrane. When there's a mutation in PIGA, it affects the production of these anchors, leading to proteins not being properly anchored.
Now, what disease is associated with PIGA mutations? I remember that Paroxysmal Nocturnal Hemoglobinuria (PNH) is caused by acquired mutations in PIGA. PNH is a rare acquired disorder where red blood cells are destroyed by the complement system because they lack GPI-anchored proteins like CD55 and CD59, which normally protect against complement-mediated lysis. So the core concept here is the role of PIGA in GPI anchor synthesis and its link to PNH.
Next, the correct answer would be PNH. The explanation should detail how the mutation leads to the absence of protective proteins on red blood cells, causing hemolysis. The other options, if they are other diseases like aplastic anemia, myelodysplastic syndrome, or others, need to be addressed. But since the user hasn't provided the options, I'll assume standard distractors.
For the clinical pearl, it's important to remember that PNH is an acquired disorder, not inherited, and that it's associated with complement deficiency on the cell surface. Also, the treatment with eculizumab, a complement inhibitor, is a key point.
Now, structuring the explanation according to the user's sections: Core Concept, Why Correct is Right, Why Wrong Options are Wrong, Clinical Pearl, and Correct Answer. Need to ensure each section is concise and within the character limit. Use bold for key terms. Avoid markdown except for bold and sections as specified. Check for medical accuracy and clarity for postgraduate students.
**Core Concept**
The PIGA gene encodes a key enzyme in glycosylphosphatidylinositol (GPI) anchor synthesis. GPI anchors are critical for membrane attachment of proteins like CD55 and CD59, which protect cells from complement-mediated lysis. Acquired somatic mutations in PIGA lead to defective GPI anchor production, causing cellular vulnerability.
**Why the Correct Answer is Right**
Acquired PIGA mutations underlie **Paroxysmal Nocturnal Hemoglobinuria (PNH)**. These mutations occur in hematopoietic stem cells, leading to red blood cells and platelets lacking GPI-anchored complement regulators (CD55 and CD59). Without these, cells are susceptible to uncontrolled complement activation, resulting in intravascular hemolysis, hemoglobinuria, and thrombosis. PNH is distinct from inherited GPI deficiencies and is a clonal disorder.
**Why Each Wrong Option is Incorrect**
**Option A:** *Not applicable* (options not provided).
**Option B:** *Not applicable* (options not provided).
**Option C:** *Not applicable* (options not provided).
**Option D:**